Lantern Pharma (LTRN) Tops Q1 EPS by 12c

Lantern Pharma (NASDAQ: LTRN) reported Q1 EPS of ($0.36), $0.12 better than the analyst estimate of ($0.48).

For earnings history and earnings-related data on Lantern Pharma (LTRN) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Morgan Stanley Starts OGE Energy (OGE) at Equalweight
• JPMorgan Downgrades Wipro Ltd. (WPRO:IN) (WIT) to Underweight